Stonegate Investment Group’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-3,478
Closed -$230K – 332
2022
Q1
$230K Buy
3,478
+186
+6% +$12.7K 0.01% 230
2021
Q4
$329K Buy
+3,292
New +$340K 0.01% 204

Other funds holding GH

Stonegate Investment Group's GH Position: Q2 2022 in Review

Stonegate Investment Group sold out of Guardant Health (GH) in Q2 2022, closing a stake of 3,478 shares — an estimated $230K sold.

Stonegate Investment Group first reported a position in GH in Q4 2021 and held it in 2 quarters. The position peaked at $329K in Q4 2021. 332 funds tracked by Wall St. Rank hold GH as of Q2 2022.

  • Stonegate Investment Group reported no remaining Guardant Health position as of Q2 2022 after selling out during the quarter.
  • Stonegate Investment Group sold 3,478 Guardant Health shares in Q2 2022, an estimated $230K.
  • Stonegate Investment Group first reported a position in Guardant Health in Q4 2021 and held it in 2 quarters.
  • Stonegate Investment Group's Guardant Health position peaked at $329K in Q4 2021.
  • 332 funds tracked by Wall St. Rank held Guardant Health as of Q2 2022.

Based on Stonegate Investment Group's 13F filing for Q2 2022, filed 9 Aug 2022.